Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

glembatumumab vedotin

An antibody-drug conjugate, consisting of the fully human monoclonal antibody CR011 directed against glycoprotein NMB (GPNMB) and conjugated via a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND The prognosis is poor for children and adolescents with recurrent osteosarcoma (OS). Glycoprotein non-metastatic B… Expand
Is this relevant?
Review
2019
Review
2019
Background gpNMB is an internalizable transmembrane protein overexpressed in ˜40% of TNBC, and associated with a worse prognosis… Expand
Is this relevant?
2017
2017
109Background: gpNMB is an internalizable transmembrane glycoprotein expressed in melanoma and multiple other tumor types. The… Expand
Is this relevant?
2016
2016
BACKGROUND Cure rates for children and young adults with osteosarcoma have remained stagnant over the past three decades… Expand
  • figure 1
  • table I
  • figure 2
  • table II
  • figure 3
Is this relevant?
2016
2016
1st Complete Response A Phase 2 Study of Glembatumumab Vedotin (GV), an Antibody-Drug Conjugate (ADC) Targeting gpNMB, in… Expand
Is this relevant?